title: Immediate outcomes of eptifibatide therapy during intracoronary stent implantation.
abstract: BACKGROUND
  The objective of the present study was to assess the major immediate outcomes of eptifibatide therapy during intracoronary stent implantation.
  
  
  METHODS
  In an interventional study, patients undergoing percutaneous coronary intervention (PCI) were randomized into either the eptifibatide (n= 100) or the control (n= 107) group. In each group, demographic and clinical characteristics such as cardiac death, stent thrombosis (ST), myocardial infarction (MI), rates of target lesion and vessel revascularization, cerebral vascular accident (CVA), and emergency coronary artery bypass grafting (CABG) were recorded.
  
  
  RESULTS
  The overall rates of major adverse events such as mortality, Stent thrombosis (ST), Myocardial Infarction (MI), target lesion revascularization (TLR), target vessel revascularization (TVR), CVA, and emergency CABG within 24 h after stent implantation were low and comparable between the two groups;P> 0.05 considered significant for all comparisons.
  
  
  CONCLUSIONS
  There were no statistical differences between the clinical outcomes of groups administered with single-dose intracoronary eptifibatide and control groups among patients undergoing PCI during stent implantation.
authors.affiliation: Isfahan Cardiovascular Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran.
authors.forename: Hooman
authors.initials: H
authors.lastname: Shariati
authors.affiliation: Isfahan Cardiovascular Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran.
authors.forename: Hamid
authors.initials: H
authors.lastname: Sanei
authors.affiliation: Isfahan Cardiovascular Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran.
authors.forename: Ali
authors.initials: A
authors.lastname: Pourmoghadas
authors.affiliation: Interventional Cardiologist, Chamran Hospital, Isfahan University of Medical Sciences, Isfahan, Iran.
authors.forename: Leila
authors.initials: L
authors.lastname: Salehizadeh
authors.affiliation: Isfahan Cardiovascular Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran.
authors.forename: Afshin
authors.initials: A
authors.lastname: Amirpour
keywords: Eptifibatide; immediate clinical outcome; percutaneous coronary intervention; stent implantation